These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15502159)
1. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus. Pan G; Pei D J Biol Chem; 2005 Jan; 280(2):1401-7. PubMed ID: 15502159 [TBL] [Abstract][Full Text] [Related]
2. Aromatic residues in the C-terminal domain 2 are required for Nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells. Wang Z; Ma T; Chi X; Pei D J Biol Chem; 2008 Feb; 283(8):4480-9. PubMed ID: 18086680 [TBL] [Abstract][Full Text] [Related]
3. The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency. Ma T; Wang Z; Guo Y; Pei D J Biol Chem; 2009 Jun; 284(24):16071-16081. PubMed ID: 19366700 [TBL] [Abstract][Full Text] [Related]
4. Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. Pan GJ; Pei DQ Cell Res; 2003 Dec; 13(6):499-502. PubMed ID: 14728807 [TBL] [Abstract][Full Text] [Related]
5. Intramolecular control of transcriptional activity by the NK2-specific domain in NK-2 homeodomain proteins. Watada H; Mirmira RG; Kalamaras J; German MS Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9443-8. PubMed ID: 10944215 [TBL] [Abstract][Full Text] [Related]
6. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells. Do HJ; Lee WY; Lim HY; Oh JH; Kim DK; Kim JH; Kim T; Kim JH J Cell Biochem; 2009 Apr; 106(6):1079-89. PubMed ID: 19229867 [TBL] [Abstract][Full Text] [Related]
7. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells. Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768 [TBL] [Abstract][Full Text] [Related]
8. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells. Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770 [TBL] [Abstract][Full Text] [Related]
9. Identification of a putative transactivation domain in human Nanog. Oh JH; Do HJ; Yang HM; Moon SY; Cha KY; Chung HM; Kim JH Exp Mol Med; 2005 Jun; 37(3):250-4. PubMed ID: 16000880 [TBL] [Abstract][Full Text] [Related]
10. Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells. Das S; Jena S; Levasseur DN J Biol Chem; 2011 Dec; 286(49):42690-42703. PubMed ID: 21969378 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. Shi W; Wang H; Pan G; Geng Y; Guo Y; Pei D J Biol Chem; 2006 Aug; 281(33):23319-25. PubMed ID: 16714766 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the human NANOG protein. Chang DF; Tsai SC; Wang XC; Xia P; Senadheera D; Lutzko C Stem Cells; 2009 Apr; 27(4):812-21. PubMed ID: 19350681 [TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog. Kim JS; Kim J; Kim BS; Chung HY; Lee YY; Park CS; Lee YS; Lee YH; Chung IY Exp Mol Med; 2005 Dec; 37(6):601-7. PubMed ID: 16391521 [TBL] [Abstract][Full Text] [Related]
14. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Kuroda T; Tada M; Kubota H; Kimura H; Hatano SY; Suemori H; Nakatsuji N; Tada T Mol Cell Biol; 2005 Mar; 25(6):2475-85. PubMed ID: 15743839 [TBL] [Abstract][Full Text] [Related]
15. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Chambers I; Colby D; Robertson M; Nichols J; Lee S; Tweedie S; Smith A Cell; 2003 May; 113(5):643-55. PubMed ID: 12787505 [TBL] [Abstract][Full Text] [Related]
16. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis. Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798 [TBL] [Abstract][Full Text] [Related]
18. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. Zhang X; Zhang J; Wang T; Esteban MA; Pei D J Biol Chem; 2008 Dec; 283(51):35825-33. PubMed ID: 18957414 [TBL] [Abstract][Full Text] [Related]
19. Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. Mullin NP; Gagliardi A; Khoa LTP; Colby D; Hall-Ponsele E; Rowe AJ; Chambers I J Mol Biol; 2017 May; 429(10):1544-1553. PubMed ID: 27939294 [TBL] [Abstract][Full Text] [Related]
20. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Theunissen TW; Costa Y; Radzisheuskaya A; van Oosten AL; Lavial F; Pain B; Castro LF; Silva JC Development; 2011 Nov; 138(22):4853-65. PubMed ID: 22028025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]